Targeting Macrophage Subsets for Infarct Repair

被引:78
作者
Ben-Mordechai, Tamar [1 ,2 ,3 ]
Palevski, Dahlia [1 ,2 ,3 ]
Glucksam-Galnoy, Yifat [4 ]
Elron-Gross, Inbar [4 ]
Margalit, Rimona [4 ]
Leor, Jonathan [1 ,2 ,3 ]
机构
[1] Tel Aviv Univ, Neufeld Cardiac Res Inst, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[2] Chaim Sheba Med Ctr, Leviev Heart Ctr, Tamman Cardiovasc Res Inst, IL-52621 Tel Hashomer, Israel
[3] Sheba Ctr Regenerat Med Stem Cell & Tissue Engn, Tel Hashomer, Israel
[4] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel
关键词
heart; liposomes; macrophage; monocyte; myocardial infarction; nanomedicine; theranostic; MESENCHYMAL STEM-CELLS; BLOOD MONOCYTE SUBSETS; NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; ALTERNATIVE ACTIVATION; CARDIAC MACROPHAGES; HEME OXYGENASE-1; HEART-FAILURE; INFLAMMATORY MONOCYTES; THYMOSIN BETA-4;
D O I
10.1177/1074248414534916
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Macrophages are involved in every cardiovascular disease and are an attractive therapeutic target. Macrophage activation is complex and can be either beneficial or deleterious, depending upon its mode of action, its timing, and its duration. An important macrophage characteristic is its plasticity, which enables it to switch from one subset to another. Macrophages, which regulate healing and repair after myocardial infarction, have become a major target for both treatment and diagnosis (theranostic). The aim of the present review is to describe the recent discoveries related to targeting and modulating of macrophage function to improve infarct repair. We will briefly review macrophage polarization, plasticity, heterogeneity, their role in infarct repair, regeneration, and cross talk with mesenchymal cells. Particularly, we will focus on the potential of macrophage targeting in situ by liposomes. The ability to modulate macrophage function could delineate pathways to reactivate the endogenous programs of myocardial regeneration. This will eventually lead to development of small molecules or biologics to enhance the endogenous programs of regeneration and repair.
引用
收藏
页码:36 / 51
页数:16
相关论文
共 178 条
[1]
Human Macrophage Regulation Via Interaction With Cardiac Adipose Tissue-Derived Mesenchymal Stromal Cells [J].
Adutler-Lieber, Shimrit ;
Ben-Mordechai, Tammar ;
Naftali-Shani, Nili ;
Asher, Elad ;
Loberman, Dan ;
Raanani, Ehud ;
Leor, Jonathan .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 18 (01) :78-86
[2]
Mononuclear phagocyte system in kidney disease and repair [J].
Alikhan, Maliha A. ;
Ricardo, Sharon D. .
NEPHROLOGY, 2013, 18 (02) :81-91
[3]
THERAPY OF LEISHMANIASIS - SUPERIOR EFFICACIES OF LIPOSOME-ENCAPSULATED DRUGS [J].
ALVING, CR ;
STECK, EA ;
CHAPMAN, WL ;
WAITS, VB ;
HENDRICKS, LD ;
SWARTZ, GM ;
HANSON, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (06) :2959-2963
[4]
Iron-oxide Labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium [J].
Amsalem, Yoram ;
Mardor, Yael ;
Feinberg, Micha S. ;
Landa, Natalie ;
Miller, Liron ;
Daniels, Dianne ;
Ocherashvilli, Aharon ;
Holbova, Radka ;
Yosef, Orna ;
Barbash, Israel M. ;
Leor, Jonathan .
CIRCULATION, 2007, 116 (11) :I38-I45
[5]
P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice [J].
An, Guangyu ;
Wang, Huan ;
Tang, Rong ;
Yago, Tadayuki ;
McDaniel, J. Michael ;
McGee, Samuel ;
Huo, Yuqing ;
Xia, Lijun .
CIRCULATION, 2008, 117 (25) :3227-3237
[6]
Fractalkine preferentially mediates arrest and migration of CD16+ monocytes [J].
Ancuta, P ;
Rao, R ;
Moses, A ;
Mehle, A ;
Shaw, SK ;
Luscinskas, FW ;
Gabuzda, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1701-1707
[7]
Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+and CD16-monocyte subsets [J].
Ancuta, Petronela ;
Liu, Kuang-Yu ;
Misra, Vikas ;
Wacleche, Vanessa Sue ;
Gosselin, Annie ;
Zhou, Xiaobo ;
Gabuzda, Dana .
BMC GENOMICS, 2009, 10 :403
[8]
Open-label study of hemin for acute porphyria: Clinical practice implications [J].
Anderson, Karl E. ;
Collins, Stephen .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (09) :801.e19-801.e24
[9]
[Anonymous], CHEM RES TOXICOL
[10]
[Anonymous], FEBS J